Growth Metrics

Nuwellis (NUWE) Short-term Investments (2021 - 2023)

Nuwellis posted quarterly Short-term Investments of $575000.0 for Q1 2023, up 1.05% on a QoQ basis from $569000.0 in Q4 2022.

Nuwellis (NUWE) has 3 years of Short-term Investments data on file, last reported at $575000.0 in Q1 2023.

  • For the quarter ending Q1 2023, Short-term Investments changed N/A year-over-year to $575000.0; the trailing twelve-month figure through Mar 2023 stood at $575000.0 (changed N/A YoY), and the FY2022 full-year result was $569000.0, down 96.32% from the prior year.
  • Short-term Investments for Q1 2023 stood at $575000.0, up from $569000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $15.5 million in Q4 2021 and bottomed at $569000.0 in Q4 2022.
  • The 3-year median for Short-term Investments is $575000.0 (2023), against an average of $5.5 million.
  • Peak annual rise in Short-term Investments reached 96.32% in 2022, while the deepest fall reached 96.32% in 2022.
  • A 3-year view of Short-term Investments shows it stood at $15.5 million in 2021, then slumped by 96.32% to $569000.0 in 2022, then rose by 1.05% to $575000.0 in 2023.
  • The last three Short-term Investments figures came in at $575000.0 (Q1 2023), $569000.0 (Q4 2022), and $15.5 million (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2023 575,000.00
Dec 31, 2022 569,000.00
Dec 31, 2021 15.46 Mn